A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder

Table 2 LS Mean (SE) SKAMP Scores at Predose and 1.5 and 13.0 Hours Postdose*

	SKAMP-D LS Mean (SE)		SKAMP-A LS Mean (SE)		SKAMP-Quality of Work LS Mean (SE)		SKAMP-Total LS Mean (SE)
	LDX	Placebo	LDX	Placebo	LDX	Placebo	LDX	Placebo
Predose	0.88 (0.09)	0.71 (0.09)	1.50 (0.10)^†	1.21 (0.10)	2.90 (0.08)^†	1.72 (0.08)	1.68 (0.07)^†	1.22 (0.07)
1.5 hours	0.70 (0.09)^†	1.14 (0.09)	1.03 (0.10)^†	1.45 (0.10)	1.75 (0.09)	1.95 (0.09)	1.15 (0.08)^†	1.62 (0.08)
13 hours	1.05 (0.10)^†	1.31 (0.10)	1.14 (0.10)^†	1.61 (0.10)	2.13 (0.10)^†	2.46 (0.10)	1.43 (0.08)^†	1.85 (0.08)

LS: least squares; LDX: lisdexamfetamine dimesylate; SKAMP: Swanson, Kotkin, Agler, M-Flynn, and Pelham scale; D: deportment; A: attention
*Lower SKAMP total and subscale scores are indicative of improvement.
^†P < .005 vs placebo.

ISSN: 1753-2000